n (%) | Univariable analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P value | Harzard ratio | 95% CI | P value | ||
Gender | .079 | .564 | |||||
Male | 23 (67.6) | ||||||
Female | 11 (32.4) | ||||||
Age | .756 | ||||||
≤ 60 | 17 (50.0) | ||||||
> 60 | 17 (50.0) | ||||||
BMI | .233 | ||||||
≤ 30 | 25 (73.5) | ||||||
> 30 | 9 (26.5) | ||||||
ASA | .054 | .266 | |||||
≤ II | 22 (64.7) | ||||||
> II | 12 (35.3) | ||||||
CVD | .612 | ||||||
Present | 10 (29.4) | ||||||
Absent | 24 (70.6) | ||||||
CKD | .606 | ||||||
Present | 3 (8.8) | ||||||
Absent | 31 (91.2) | ||||||
DM | .593 | ||||||
Present | 2 (5.9) | ||||||
Absent | 32 (94.1) | ||||||
CRD | .441 | ||||||
Present | 7 (20.6) | ||||||
Absent | 27 (79.4) | ||||||
History of malignancy | .358 | ||||||
Present | 6 (17.6) | ||||||
Absent | 28 (82.4) | ||||||
Type of IBD | .021 | .021 | |||||
Ulcerative colitis | 15 (44.1) | 11.68 | 1.45–93.57 | 11.68 | 1.45–93.57 | ||
Crohn`s disease | 19 (55.9) | 1 | 1 | ||||
History of > 1 bowel resection | .035 | .096 | |||||
Yes | 8 (23.5) | 4.64 | 1.11–19.32 | ||||
No | 26 (76.5) | 1 | |||||
Extraintestinal manifestation | .030 | .339 | |||||
Present | 4 (11.8) | 4.98 | 1.17–21.29 | ||||
Absent | 30 (88.2) | 1 | |||||
Corticosteroid | .606 | ||||||
Yes | 2 (5.9) | ||||||
No | 32 (94.1) | ||||||
Mesalazine | .888 | ||||||
Yes | 8 (23.5) | ||||||
No | 26 (76.5) | ||||||
Immunosuppresion | .317 | ||||||
Yes | 7 (20.6) | ||||||
No | 27 (79.4) | ||||||
Intraoperative blood transfusion | .606 | ||||||
Yes | 3 (8.8) | ||||||
No | 31 (91.2) | ||||||
Intensive care | .396 | ||||||
Yes | 8 (23.5) | ||||||
No | 26 (76.5) | ||||||
≥ Clavien-Dindo I | .513 | ||||||
Yes | 14 (41.2) | ||||||
No | 20 (58.8 | ||||||
≥ Clavien-Dindo IIIb | .940 | ||||||
Yes | 7 (20.6) | ||||||
No | 27 (79.4) | ||||||
SSI | .967 | ||||||
Yes | 5 (14.7) | ||||||
No | 28 (82.4) | ||||||
Seroma | .995 | ||||||
Yes | 9 (26.5) | ||||||
No | 25 (73.5) | ||||||
Relaparotomy | .967 | ||||||
Yes | 5 (14.7) | ||||||
No | 29 (85.3) |